IP Library Granted Patent US 12,048,721
Granted Patent B2
US 12,048,721 · App. 16/830,881 · Granted Jul 30, 2024

Compositions of microbiota and methods related thereto

Inventors: Lee M. Kaplan (Wellesley, MA); Alice P. Liou (Charlestown, MA); Peter J. Turnbaugh (Somerville, MA); Jason L. Harris (Lebanon, OH)
Assignees: The General Hospital Corporation; Presidents and Fellows of Harvard College; Johnson & Johnson Consumer Inc.
A61K35/74A61K9/0053A61K35/741A61K45/06C12Q1/689A61K2035/11Y02A50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,048,721
App. No.
16/830,881
Granted
Jul 30, 2024
Kind
B2
Abstract

Methods and compositions are provided for treating weight related conditions and metabolic disorders by altering microbiota in a subject. One aspect provides methods and compositions to alter microbiota in a subject by administering to the subject a composition that includes a substantially purified microbiota from phyla such as Bacteroidetes, Proteobacteria, Firmicutes and Verrucomicrobia or orders such as Bacteroidales, Verrucomicrobiales, Clostridiales and Enterobacteriales or genera such as Alistipes, Clostridium, Escherichia , and Akkermansia . Another aspect includes a pharmaceutical composition for altering microbiota that includes a therapeutically effective amount of substantially purified microbiota and a pharmaceutically acceptable carrier. Yet another aspect includes methods for treating a disorder, such as obesity, in a subject in need of such treatment by changing relative abundance of microbiota in a gastrointestinal tract of the subject without or in addition to a surgical procedure.

Claims (7)

1. A composition formulated for oral delivery comprising a substantially purified Verrucomicrobia, a non-viable bacterial structural component specific to Verrucomicrobia that alters a relative abundance of microbiota in a subject, and an effective amount of a stabilizer,

wherein the composition is in the form of a tablet, pill or powder.

2. The composition of claim 1 , wherein the non-viable component comprises a protein.

3. The composition of claim 2 , wherein the non-viable component specific to Verrucomicrobia comprises a lipid, a carbohydrate, a lipoprotein, glycolipid, glycoprotein, or a combination thereof.

4. The composition of claim 1 , wherein the Verrucomicrobia is lyophilized.

5. The composition of claim 1 , wherein the composition further comprises a preservative.

6. The composition of claim 1 , wherein the substantially purified Verrucomicrobia is encapsulated in a coating that does not begin to degrade until it exits the stomach.

Assignments (9)
CHANGE OF NAME Recorded Oct 28, 2024
From: JOHNSON & JOHNSON CONSUMER INC.
To: KENVUE BRANDS LLC
Reel/Frame 069267/0143 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2023
From: JOHNSON & JOHNSON CONSUMER INC.
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 062438/0372 →
CERTIFICATE OF CONVERSION Recorded Jan 19, 2023
From: JOHNSON & JOHNSON CONSUMER INC.
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 062438/0521 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2023
From: ETHICON ENDO-SURGERY, INC.
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 062341/0767 →
SECURITY INTEREST Recorded Jan 18, 2022
From: PENDULUM THERAPEUTICS, INC.
To: TRINITY CAPITAL INC.
Reel/Frame 058678/0276 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2020
From: TURNBAUGH, PETER J.
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 054128/0957 →
QUITCLAIM ASSIGNMENT Recorded Oct 21, 2020
From: THE GENERAL HOSPITAL CORPORATION D/B/A MASSACHUSETTS GENERAL HOSPITAL
To: TURNBAUGH, PETER J.
Reel/Frame 054171/0725 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2020
From: HARRIS, JASON L.
To: ETHICON ENDO-SURGERY, INC.
Reel/Frame 054128/0664 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2020
From: KAPLAN, LEE M.; LIOU, ALICE P.; TURNBAUGH, PETER J.
To: THE GENERAL HOSPITAL CORPORATION D/B/A MASSACHUSETTS GENERAL HOSPITAL
Reel/Frame 054128/0519 →